Microbiology · Year 2 · from Microbiology
Case 1: Toxin-Mediated Disease
Presentation
A 19-year-old college student is brought to the emergency department by her roommate with high fever, diffuse rash, and confusion that developed over the past 12 hours. She had been feeling well until yesterday when she developed body aches and fatigue. Her roommate mentions she is on her menstrual period and uses tampons.
Physical examination reveals temperature 40.1°C, heart rate 130 bpm, blood pressure 78/45 mmHg, and respiratory rate 28/min. She has a diffuse erythematous "sunburn-like" rash affecting her entire body, including palms and soles. Conjunctival injection and strawberry tongue are noted. There are no focal findings on examination. Laboratory studies show WBC 18,000/μL with 15% bands, platelets 85,000/μL, creatinine 2.4 mg/dL, and AST 156 U/L.
Clinical Image
Mechanisms of bacterial pathogenesis including toxin production, adhesion, and invasion - critical for understanding how bacteria cause disease.
Image Source: Lecture image - pathogenesis mechanisms
Questions
- What is the most likely diagnosis, and what organism is responsible?
- Explain the mechanism by which this toxin causes such widespread systemic effects despite originating from a localized infection.
- What is the difference between this type of toxin and an A-B toxin like diphtheria toxin?
- Why does this patient have evidence of multi-organ dysfunction (elevated creatinine, low platelets, elevated liver enzymes)?
Answers
- Most likely diagnosis: Staphylococcal Toxic Shock Syndrome (TSS) caused by Staphylococcus aureus producing toxic shock syndrome toxin-1 (TSST-1). The classic presentation includes rapid onset of high fever, diffuse erythematous rash, hypotension, and multi-organ involvement, occurring in the setting of tampon use. Menstrual TSS occurs when S. aureus colonizing the vagina produces TSST-1, which is absorbed through the vaginal mucosa into systemic circulation.
- Mechanism of superantigen toxin: TSST-1 is a superantigen that causes disease through a unique mechanism of immune hyperactivation:
- Unlike conventional antigens that are processed and presented to specific T cells (activating 0.01% of T cells), superantigens bypass normal antigen processing
- TSST-1 binds directly to MHC class II molecules on antigen-presenting cells and to the Vβ region of T cell receptors outside the antigen-binding groove
- This cross-linking activates up to 20% of all T cells simultaneously
- Massive polyclonal T cell activation triggers a "cytokine storm" - release of enormous amounts of IL-2, TNF-α, IL-1, and IFN-γ
- These cytokines cause the systemic inflammatory response: fever (hypothalamic effects), vasodilation and capillary leak (hypotension), and end-organ damage
- Superantigen vs. A-B toxin:
| Feature | Superantigen (TSST-1) | A-B Toxin (Diphtheria) | |---------|----------------------|------------------------| | Structure | Single polypeptide | Two functional domains (Active + Binding) | | Target | Immune cells (T cells, APCs) | Specific cell types via receptors | | Mechanism | Cross-links MHC II to TCR | B subunit binds receptor, A subunit has enzymatic activity | | Effect | Massive cytokine release | Direct cell killing (EF-2 inactivation, protein synthesis block) | | Cell entry | Not required | Required for A subunit action |
- Multi-organ dysfunction mechanism: The cytokine storm from superantigen activation causes:
- Hypotension: TNF-α and IL-1 cause vasodilation and increased capillary permeability, leading to distributive shock with third-spacing of fluid
- Acute kidney injury (elevated creatinine): Hypoperfusion and direct cytokine effects on renal tubules
- Thrombocytopenia: DIC with platelet consumption; cytokine-mediated platelet sequestration
- Elevated liver enzymes: Hypoxic hepatitis from poor perfusion and direct cytokine-mediated hepatocyte injury
- Rash: Cytokine effects on dermal vasculature
Treatment requires aggressive fluid resuscitation, removal of the source (tampon removal, wound debridement), and antibiotics including clindamycin (which inhibits toxin production by inhibiting protein synthesis).